Status: current, Defined. Date: 31-Oct 2021. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4632551000168110 | Crysvita (burosumab 30 mg / 1 mL) injection, 1 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4632561000168112 | Crysvita 30 mg/mL injection, 1 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Crysvita 30 mg/mL injection, 1 mL vial | Is a | Crysvita | true | Inferred relationship | Some | ||
Crysvita 30 mg/mL injection, 1 mL vial | Is a | burosumab 30 mg/mL injection, vial | true | Inferred relationship | Some | ||
Crysvita 30 mg/mL injection, 1 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Crysvita 30 mg/mL injection, 1 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
Crysvita 30 mg/mL injection, 1 mL vial | has Australian BoSS | burosumab | true | Inferred relationship | Some | 2011305934 | |
Crysvita 30 mg/mL injection, 1 mL vial | has intended active ingredient | burosumab | true | Inferred relationship | Some | 2011305934 | |
Crysvita 30 mg/mL injection, 1 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1786325657 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Crysvita 30 mg/mL injection, 1 mL vial | has TPUU | True | Crysvita 30 mg/mL injection, 1 mL vial | Inferred relationship | Some | 1671554532 |
Crysvita 30 mg/mL injection, 1 mL vial | has TPUU | True | Crysvita 30 mg/mL injection, 1 mL vial | Inferred relationship | Some | 1758211235 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set